Related Experiment Video
Updated: May 12, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Association Between Perceived COVID-19 Risk and Current Use of Any Nicotine Product Amongst Adolescents in Saudi
Najim Z Alshahrani1, Abdullah M Alarifi2,3, Ibrahim Alasqah4,5
1Department of Family and Community Medicine, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Introduction:
The COVID-19 pandemic created a unique context for tobacco-related risk communication amongst adolescents. This study examined the link between COVID-19-related smoking risk perceptions and current nicotine use amongst Saudi school adolescents.
Methods:
Data were drawn from the 2022 Saudi Arabia Global Youth Tobacco Survey, a nationally representative school-based survey (overall response rate: 92.3%). The analytic sample included 4984 adolescents aged 13-15 years. The primary outcome was current use (≥ 1 day in the past 30 days) of any nicotine product, including cigarettes, shisha, smokeless tobacco, heated tobacco products and electronic cigarettes. Key exposures were beliefs about whether smoking affects COVID-19 infection risk and illness severity. Survey-weighted logistic regression estimated crude and adjusted odds ratios (aOR), adjusting for sex, grade, weekly spending, parental and peer smoking and school tobacco education. Product-specific sensitivity analyses were performed.
Results:
Overall, 10.7% of adolescents reported current nicotine use. Adolescents who believed smoking reduced the risk of COVID-19 infection had higher odds of nicotine use compared with those who believed it increased risk (aOR = 3.77; 95% CI 2.52-5.65). Similarly, perceiving that smoking reduced COVID-19 severity was associated with higher odds of use (aOR = 2.34; 95% CI 1.49-3.67). In sensitivity analyses, associations for perceived reduced infection risk were observed for both cigarette smoking (aOR = 4.44; 95% CI 2.83-6.99) and non-cigarette nicotine use (aOR = 4.09; 95% CI 2.96-5.66).
Discussion And Conclusions:
Beliefs that smoking lowers COVID-19 risks are strongly linked to adolescent nicotine use, underscoring the need for accurate risk communication in youth tobacco prevention.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Stress Prevention and Stress Management Techniques IV
Relative Risk
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Criteria for Causality: Bradford Hill Criteria - II
